0001843113-22-000010.txt : 20221018 0001843113-22-000010.hdr.sgml : 20221018 20221018203811 ACCESSION NUMBER: 0001843113-22-000010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221016 FILED AS OF DATE: 20221018 DATE AS OF CHANGE: 20221018 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ABALLI JOHN CENTRAL INDEX KEY: 0001843113 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39049 FILM NUMBER: 221317072 MAIL ADDRESS: STREET 1: C/O DECIPHER BIOSCIENCES, INC. STREET 2: 6925 LUSK BLVD, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EXAGEN INC. CENTRAL INDEX KEY: 0001274737 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1261 LIBERTY WAY CITY: VISTA STATE: CA ZIP: 92081 BUSINESS PHONE: (760) 560-1501 MAIL ADDRESS: STREET 1: 1261 LIBERTY WAY CITY: VISTA STATE: CA ZIP: 92081 FORMER COMPANY: FORMER CONFORMED NAME: EXAGEN DIAGNOSTICS INC DATE OF NAME CHANGE: 20031230 4 1 wf-form4_166613985172902.xml FORM 4 X0306 4 2022-10-16 0 0001274737 EXAGEN INC. XGN 0001843113 ABALLI JOHN C/O EXAGEN INC. 1261 LIBERTY WAY VISTA CA 92081 1 1 0 0 President and CEO Restricted Stock Units 2022-10-16 4 A 0 350000 0 A 350000 D The securities awarded are in the form of restricted stock units under the issuer's 2019 Incentive Award Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The restricted stock unit will vest with respect to 25% of the restricted stock units on each of the first, second, third and fourth anniversaries of October 16, 2022, subject to the Reporting Person's continued service through the applicable vesting date. In addition, the award may become fully vested upon a qualifying termination of employment in connection with a change in control. /s/ Kamal Adawi, as attorney-in-fact 2022-10-18